Androgens, growth factors, and risk of prostate cancer: The Multiethnic Cohort
Authors:
- 17 February 2010
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 70 (8) , 906-915
Abstract
BACKGROUND: Androgens and growth factors are thought to be associated with prostate cancer risk, although past research has produced mixed results.METHODS: We conducted a nested case–control study of biomarkers of prostate cancer risk within the Multiethnic Cohort. We compared prediagnostic levels of testosterone, dihydrotestosterone (DHT), sex hormone‐binding globulin (SHBG), 3α‐androstanediol glucuronide (3α‐diol G), insulin‐like growth factor I (IGF‐I), IGF‐II, IGF‐binding protein 1 (IGFBP‐1), and IGFBP‐3 in serum from 467 incident prostate cancer cases and 934 cancer‐free controls. Controls were matched to the cases on geographic site (HI, LA), ethnicity, age at specimen collection (±1 year), date (±1 month) and time of day (±2 hr) of sample collection, and fasting status (10 hr). Multivariate conditional logistic regression models were used to compute adjusted odds ratios (ORs) and 95% confidence intervals (CIs).RESULTS: Serum concentrations of testosterone, DHT, SHBG, 3α‐diol G, IGF‐I, IGF‐II, IGFBP‐1, and IGFBP‐3 were not associated with risk of prostate cancer. Tests for trend of quartiles of serum concentrations also did not show any association. Results were relatively unchanged for men with advanced prostate cancer and their matched controls. However, the follow‐up period was relatively short (mean of 1.9 years). Analysis by ethnic group showed an increased risk for Latino men in the second (OR = 3.67, 95% CI: 1.63–8.24) and third (OR = 2.96, 95% CI: 1.19–7.40) tertiles of IGF‐I serum levels compared with the first tertile.CONCLUSIONS: The suggested increased risk for IGF‐I in Latino men merits further study, with greater statistical power. Prostate 70: 906–915, 2010.Keywords
Funding Information
- USPHS (R37 CA 54281)
This publication has 27 references indexed in Scilit:
- Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and NutritionInternational Journal of Cancer, 2007
- IGF‐1 and IGFBP‐3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening TrialInternational Journal of Cancer, 2007
- Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and NutritionCancer Epidemiology, Biomarkers & Prevention, 2007
- IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-AmericansCarcinogenesis, 2007
- Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States)Cancer Causes & Control, 2006
- Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Prostate CancerCancer Epidemiology, Biomarkers & Prevention, 2006
- Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA eraCancer Causes & Control, 2005
- High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective studyInternational Journal of Cancer, 2003
- Insulin‐like growth factors and risk of benign prostatic hyperplasia†The Prostate, 2002
- Prospective Study of Sex Hormone Levels and Risk of Prostate CancerJNCI: Journal of the National Cancer Institute, 1996